Delivery Order SPE2DB24D1021-SPE2DB25FFAFF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,827.28 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on July 31, 2025, with completion targeted for August 1, 2025. This firm fixed price delivery order, awarded without set-aside designation through competitive procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $6,697.07 on August 12, 2025, for TYPHIM VI 25 MCG/0.5 ML vials (10 mL units). This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is scheduled for completion by August 13, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine used for...
- The Defense Logistics Agency awarded a delivery order valued at $12,086.06 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. This firm fixed price, non-set-aside delivery order was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,162.72 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on August 20, 2025, with a completion date of August 21, 2025. This firm fixed-price delivery order is non-competitive and utilizes no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply contract. The award represents a child delivery order under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,320.14 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vials (10 mL quantity) on August 28, 2025, with completion expected by August 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine indicated for immunization against typhoid infection, serving...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,213.67 for TYPHIM VI 25 MCG/0.5 ML vial (10 mL) on August 21, 2025, with completion scheduled for August 22, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded through open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,632.90 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML Vial 10ML, a typhoid vaccine product. The award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, utilized firm fixed-price pricing with no set-aside designation, indicating competitive procurement. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TYPHIM VI (typhoid vaccine) 25 mcg/0.5 mL syringes valued at $55,192.00 on August 28, 2025, with completion targeted for August 29, 2025. This competitively awarded, firm fixed-price delivery order represents a small transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The work will be performed at the company's corporate office location in...
- The Defense Logistics Agency awarded a $17,937.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 mcg/0.5 mL syringes on August 22, 2025, with an ultimate completion date of August 25, 2025. This delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. TYPHIM VI is a typhoid vaccine used for immunization purposes, and this order fulfills federal medical...
- The Defense Logistics Agency awarded a $8,632.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vials with a 10ML capacity. The contract was competitively awarded without set-aside on August 9, 2025, with an ultimate completion date of August 11, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAFFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,235.78 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML vial (10 ML) on September 4, 2025, with completion scheduled for September 5, 2025. This delivery order represents a firm fixed price, non-set-aside competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 through December 2026. TYPHIM VI is a typhoid vaccine used for immunization purposes, reflecting the pharmaceutical and medical supply support that DLA provides to military healthcare systems and other federal agencies. Performance will take place at AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's DLA Troop Support Medical prime vendor contract enables it to supply pharmaceutical products globally in support of military healthcare programs, serving customers including the Defense Health Agency and U.S. Coast Guard. This delivery order exemplifies the company's ongoing role in fulfilling federal vaccine and pharmaceutical supply requirements through open competition and firm fixed pricing mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/4/25 |